Stock Scorecard



Stock Summary for Atyr Pharma Inc (LIFE) - $1.20 as of 12/8/2023 9:09:28 PM EST

Total Score

12 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LIFE

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LIFE

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LIFE

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for LIFE

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for LIFE

aTyr Pharma ( NASDAQ:LIFE ) Upgraded by StockNews.com to "Hold" 12/9/2023 9:41:00 AM
aTyr Pharma ( NASDAQ:LIFE ) Rating Lowered to Sell at StockNews.com 11/15/2023 8:18:00 AM
Foundation for Sarcoidosis Research announces largest Global Sarcoidosis Virtual Summit - Find Your Community, Find Your Life 9/26/2023 1:15:00 PM
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes 9/11/2023 12:00:00 PM
5 Top Stocks to Play Earnings Beat Potential 9/4/2023 11:30:00 AM
Down -9.64% in 4 Weeks, Here's Why You Should You Buy the Dip in Atyr Pharma ( LIFE ) 8/30/2023 1:35:00 PM
aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference 8/24/2023 12:00:00 PM
5 Top Stocks Likely to Top Earnings Estimates 8/18/2023 11:49:00 AM
Atyr Pharma ( LIFE ) Reports Q2 Loss, Lags Revenue Estimates 8/9/2023 9:30:00 PM
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying - Eos Energy Enterprises ( NASDAQ:EOSE ) , aTyr Pharma ( NASDAQ:LIFE ) 8/2/2023 1:06:00 PM

Financial Details for LIFE

Company Overview

Ticker LIFE
Company Name Atyr Pharma Inc
Country USA
Description aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 9/30/2023
Next Earnings Date 3/7/2024

Stock Price History

Last Day Price 1.20
Last Day Price Updated 12/8/2023 9:09:28 PM EST
Last Day Volume N/A
Average Daily Volume N/A
52-Week High 2.70
52-Week Low 1.08
Last Price to 52 Week Low 11.11 %

Valuation Measures

Trailing PE N/A
Industry PE 158.38
Sector PE 62.37
5-Year Average PE -2.12
Free Cash Flow Ratio 0.69
Industry Free Cash Flow Ratio 17.89
Sector Free Cash Flow Ratio 31.15
Current Ratio Most Recent Quarter 8.33
Total Cash Per Share 1.74
Book Value Per Share Most Recent Quarter 1.68
Price to Book Ratio 0.72
Industry Price to Book Ratio 4.65
Sector Price to Book Ratio 19.59
Price to Sales Ratio Twelve Trailing Months 6.54
Industry Price to Sales Ratio Twelve Trailing Months 16.60
Sector Price to Sales Ratio Twelve Trailing Months 5.61

Share Statistics

Total Shares Outstanding 58,560,000
Market Capitalization 70,272,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Dividend King? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00 %
Annual Earnings Growth -34.26 %
Reported EPS 12 Trailing Months -0.95
Reported EPS Past Year -0.71
Reported EPS Prior Year -1.60
Net Income Twelve Trailing Months -43,150,000
Net Income Past Year -45,338,000
Net Income Prior Year -33,768,000
Quarterly Revenue Growth YOY 1,326.00 %
5-Year Revenue Growth 0.00 %

Balance Sheet

Total Cash Most Recent Quarter 102,131,000
Total Cash Past Year 66,146,000
Total Cash Prior Year 107,911,000
Net Cash Position Most Recent Quarter 102,131,000
Net Cash Position Past Year 66,146,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 71,464,000
Total Stockholder Equity Prior Year 109,301,000
Total Stockholder Equity Most Recent Quarter 98,390,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.01
MACD Signal -0.02
20-Day Bollinger Lower Band 0.93
20-Day Bollinger Middle Band 1.53
20-Day Bollinger Upper Band 2.14
Beta 1.20
RSI 51.58
50-Day SMA 1.95
200-Day SMA 3.85

System

Modified 12/9/2023 1:32:11 PM EST